{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:34:36Z","timestamp":1790224476711,"version":"4.1.0"},"reference-count":191,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtho.2026.103611","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:18:47Z","timestamp":1775823527000},"page":"103611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Challenges and Controversies in the Diagnosis and Management of Thymic Epithelial Tumors from the Thymic Tumor Subcommittee of the International Association for the Study of Lung Cancer Rare Tumors Committee"],"prefix":"10.1016","volume":"21","author":[{"given":"Fatemeh","family":"Ardeshir-Larinani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Ashrafian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Chiappetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mansilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro Wasum","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Menis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rimner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Szolkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swasthik","family":"Upadhya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Velotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Vlahos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron S.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Baas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8948-4758","authenticated-orcid":false,"given":"Anja C.","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2026.103611_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70968","article-title":"Rising threat: long-term trends in the incidence and mortality of thymic epithelial tumor","volume":"14","author":"Chen","year":"2025","journal-title":"Cancer Med"},{"key":"10.1016\/j.jtho.2026.103611_bib2","article-title":"Epidemiology of thymomas and thymic carcinomas in the United States and Germany, 1999\u20132019","volume":"13","author":"Gerber","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108554","article-title":"Therapeutic management of patients with advanced thymic malignancies: a review for clinicians","volume":"204","author":"Pavese","year":"2025","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1288045","article-title":"Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs","volume":"15","author":"Perrino","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtho.2026.103611_bib5","doi-asserted-by":"crossref","first-page":"9056","DOI":"10.3390\/ijms21239056","article-title":"Immunobiology of thymic epithelial tumors: implications for immunotherapy with immune checkpoint inhibitors","volume":"21","author":"Tateo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtho.2026.103611_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189145","article-title":"Evolving treatment landscape in thymic epithelial tumors: from mechanism to therapy","volume":"1879","author":"Yang","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib7","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.21037\/jtd-21-290","article-title":"The efficacy and safety of immunotherapy in thymic epithelial tumors: more effective, more risky: a systematic review","volume":"13","author":"Song","year":"2021","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jtho.2026.103611_bib8","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.3390\/biomedicines11102722","article-title":"Immunotherapy and targeted therapies efficacy in thymic epithelial tumors: a systematic review","volume":"11","author":"Agrafiotis","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtho.2026.103611_bib9","article-title":"Clinicogenomic landscape of metastatic thymic epithelial tumors","volume":"7","author":"Ardeshir-Larijani","year":"2023","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol Int"},{"key":"10.1016\/j.jtho.2026.103611_bib11","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"issue":"suppl 2","key":"10.1016\/j.jtho.2026.103611_bib12","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1097\/JTO.0000000000000291","article-title":"The IASLC\/ITMIG thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors","volume":"9","author":"Kondo","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib13","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jtho.2023.09.002","article-title":"The International Association for the Study of Lung Cancer thymic epithelial tumors staging project: proposal for a stage classification for the forthcoming (ninth) edition of the TNM classification of malignant tumors","volume":"18","author":"Ruffini","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/diagnostics10070460","article-title":"Diagnostic roles of immunohistochemistry in thymic tumors: differentiation between thymic carcinoma and thymoma","volume":"10","author":"Jeong","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jtho.2026.103611_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ccell.2018.01.003","article-title":"The integrated genomic landscape of thymic epithelial tumors","volume":"33","author":"Radovich","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jtho.2026.103611_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13000-015-0441-7","article-title":"Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large scale study of 1465 non-small cell lung cancer cases","volume":"10","author":"Kriegsmann","year":"2015","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jtho.2026.103611_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/his.12405","article-title":"Utility of PAX8 mouse monoclonal antibody in the diagnosis of thyroid, thymic, pleural and lung tumours: a comparison with polyclonal PAX8 antibody","volume":"65","author":"Toriyama","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.jtho.2026.103611_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00428-014-1606-6","article-title":"Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall","volume":"465","author":"Adam","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jtho.2026.103611_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/PAS.0b013e3181db84aa","article-title":"Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors","volume":"34","author":"Liu","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2026.103611_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/med.2018.12.01","article-title":"An overview on the differential diagnostics of tumors of the anterior-superior mediastinum: the pathologist\u2019s perspective","volume":"3","author":"Marino","year":"2019","journal-title":"Mediastinum"},{"key":"10.1016\/j.jtho.2026.103611_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/biomedicines11020487","article-title":"Primary mediastinal germ cell tumors: a thorough literature review","volume":"11","author":"Ozgun","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtho.2026.103611_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.6004\/jnccn.2025.0027","article-title":"Thymomas and thymic carcinomas, version 2.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Riely","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtho.2026.103611_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2463\/mrms.rev.2021-0098","article-title":"MRI findings and differential diagnosis of anterior mediastinal solid tumors","volume":"22","author":"Nakazono","year":"2023","journal-title":"Magn Reson Med Sci"},{"key":"10.1016\/j.jtho.2026.103611_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jtho.2019.12.108","article-title":"Distribution of mediastinal lesions across multi-institutional, international, radiology databases","volume":"15","author":"Roden","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107558","article-title":"Spatiotemporal distribution of mediastinal neoplasms: a comprehensive multi-center study","volume":"191","author":"Jiang","year":"2024","journal-title":"Lung Cancer"},{"issue":"suppl 5","key":"10.1016\/j.jtho.2026.103611_bib26","doi-asserted-by":"crossref","first-page":"v40","DOI":"10.1093\/annonc\/mdv277","article-title":"ESMO Guidelines Committee. Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Girard","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.athoracsur.2003.08.004","article-title":"Seeding of stage I thymoma into the chest wall 12 years after needle biopsy","volume":"79","author":"Kattach","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.crad.2023.12.009","article-title":"CT-guided pretreatment biopsy diagnosis in patients with thymic epithelial tumours: diagnostic accuracy and risk of seeding","volume":"79","author":"Ahn","year":"2024","journal-title":"Clin Radiol"},{"issue":"suppl 2","key":"10.1016\/j.jtho.2026.103611_bib29","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1097\/JTO.0000000000000295","article-title":"Approaching the patient with an anterior mediastinal mass: a guide for radiologists","volume":"9","author":"Carter","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib30","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/JS9.0000000000003600","article-title":"Total thymectomy is oncologically superior to partial thymectomy in patients with thymic carcinoma: insights from a multicenter real-world data analysis","volume":"112","author":"Hayashi","year":"2026","journal-title":"Int J Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib31","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.21037\/jtd.2017.09.109","article-title":"Could thymomectomy be a reasonable option for non-myasthenic thymoma patients?","volume":"9","author":"Tassi","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jtho.2026.103611_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/1759-7714.12542","article-title":"Is thymomectomy sufficient for non-myasthenic early stage thymoma patients? A retrospective, single center experience","volume":"9","author":"Rusidanmu","year":"2018","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2016.06.021","article-title":"Limited thymectomy as a potential alternative treatment option for early-stage thymoma: a multi-institutional propensity-matched study","volume":"101","author":"Narm","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.athoracsur.2015.07.084","article-title":"Is thymomectomy alone appropriate for Stage I (T1N0M0) thymoma? Results of a propensity-score analysis","volume":"101","author":"Nakagawa","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib35","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.lungcan.2009.08.001","article-title":"Limited thymectomy for stage I or II thymomas","volume":"68","author":"Onuki","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib36","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s13304-024-01918-z","article-title":"Early stage thymoma and the surgical extent paradigm","volume":"76","author":"Kocaman","year":"2024","journal-title":"Update Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1749-8090-9-51","article-title":"Recurrence after thymoma resection according to the extent of the resection","volume":"9","author":"Bae","year":"2014","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/icvts\/ivac167","article-title":"Thymomectomy versus complete thymectomy in early-stage non-myasthenic thymomas: a multicentric propensity score-matched study","volume":"35","author":"Voulaz","year":"2022","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/ejcts\/ezab224","article-title":"Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: a European Society of Thoracic Surgeons Thymic Working Group Study","volume":"60","author":"Guerrera","year":"2021","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib40","doi-asserted-by":"crossref","first-page":"680","DOI":"10.21037\/jtd.2016.03.16","article-title":"Thymectomy versus tumor resection for early-stage thymic malignancies: a Chinese Alliance for Research in thymomas retrospective database analysis","volume":"8","author":"Gu","year":"2016","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jtho.2026.103611_bib41","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/JTO.0b013e31828cb3c2","article-title":"Is thymectomy necessary in nonmyasthenic patients with early thymoma?","volume":"8","author":"Tseng","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib42","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejcts.2009.10.003","article-title":"Unilateral thoracoscopic subtotal thymectomy for the treatment of stage I and II thymoma","volume":"37","author":"Odaka","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib43","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00464-007-9606-0","article-title":"Alternative choices of total and partial thymectomy in video-assisted resection of noninvasive thymomas","volume":"22","author":"Sakamaki","year":"2008","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jtho.2026.103611_bib44","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jtcvs.2010.09.003","article-title":"Comparison of surgical techniques for early-stage thymoma: feasibility of minimally invasive thymectomy and comparison with open resection","volume":"141","author":"Pennathur","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib45","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.ejso.2016.03.029","article-title":"Thoracoscopic thymectomy versus open thymectomy for the treatment of thymoma: a meta-analysis","volume":"42","author":"Yang","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21037\/med-24-17","article-title":"Surgical management of thymic tumors: a narrative review with focus on robotic-assisted surgery","volume":"8","author":"Deckarm","year":"2024","journal-title":"Mediastinum"},{"key":"10.1016\/j.jtho.2026.103611_bib47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/JTO.0b013e31818e105c","article-title":"Thymoma: a focus on current therapeutic management","volume":"4","author":"Girard","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib48","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/icvts\/ivz320","article-title":"Video-assisted thoracoscopic thymectomy is feasible for large thymomas: a propensity-matched comparison","volume":"30","author":"Weng","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib49","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.athoracsur.2017.03.054","article-title":"Video-assisted thoracic surgery thymectomy versus sternotomy thymectomy in patients with thymoma","volume":"104","author":"Agatsuma","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/jovs-23-48","article-title":"Robotic resection of mediastinal masses: a decade of experience","volume":"10","author":"Grawunder","year":"2024","journal-title":"J Vis Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib51","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.athoracsur.2017.05.074","article-title":"Robotic thymectomy is feasible for large thymomas: a propensity-matched comparison","volume":"104","author":"Kneuertz","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib52","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s13193-020-01208-1","article-title":"Minimal access surgery for thymoma","volume":"11","author":"Kumar","year":"2020","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib53","first-page":"45","article-title":"The role of adjuvant chemotherapy following resection of early stage thymoma","volume":"5","author":"Hamaji","year":"2016","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib54","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/icvts\/ivab146","article-title":"Adjuvant chemotherapy improves survival outcomes after complete resection of thymic squamous cell carcinoma: a retrospective study of 116 patients","volume":"33","author":"Gao","year":"2021","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib55","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.18632\/oncotarget.24315","article-title":"Thymoma size significantly affects the survival, metastasis and effectiveness of adjuvant therapies: a population based study","volume":"9","author":"Bian","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2026.103611_bib56","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0003-4975(03)01017-8","article-title":"Lymphogenous and hematogenous metastasis of thymic epithelial tumors","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib57","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.lungcan.2019.09.024","article-title":"Prognostic factors after treatment for iterative thymoma recurrences: a multicentric experience","volume":"138","author":"Chiappetta","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.athoracsur.2012.02.092","article-title":"The role of surgical management in recurrent thymic tumors","volume":"94","author":"Hamaji","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s11748-020-01439-7","article-title":"18F-FDG-PET\/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors","volume":"69","author":"Ito","year":"2021","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib60","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00330-021-08230-z","article-title":"Diagnostic and prognostic values of 2-[18F]FDG PET\/CT in resectable thymic epithelial tumour","volume":"32","author":"Han","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jtho.2026.103611_bib61","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/JTO.0000000000000660","article-title":"Impact of positive nodal metastases in patients with thymic carcinoma and thymic neuroendocrine tumors","volume":"10","author":"Weksler","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib62","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jtcvs.2014.11.054","article-title":"Resection of thymoma should include nodal sampling","volume":"149","author":"Weksler","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib63","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00595-023-02705-w","article-title":"Long-term outcomes following surgical treatment for thymic epithelial tumor in Japan and an analysis of prognostic factors based on the Japanese Association for Research on the Thymus nationwide database","volume":"53","author":"Okumura","year":"2023","journal-title":"Surg Today"},{"key":"10.1016\/j.jtho.2026.103611_bib64","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jtho.2018.08.2026","article-title":"Impact of lymph node dissection on thymic malignancies: multi-institutional propensity score matched analysis","volume":"13","author":"Hwang","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib65","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jtho.2015.09.001","article-title":"Lymph node dissection in thymic malignancies: implication of the ITMIG lymph node map, TNM stage classification, and recommendations","volume":"11","author":"Hwang","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib66","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/icvts\/ivu281","article-title":"What is the role of lymph nodal metastases and lymphadenectomy in the surgical treatment and prognosis of thymic carcinomas and carcinoids?","volume":"19","author":"Viti","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib67","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.3390\/cancers13184516","article-title":"Evaluation of surgical therapy in advanced thymic tumors","volume":"13","author":"Markowiak","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtho.2026.103611_bib68","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.athoracsur.2010.01.057","article-title":"Preservation of phrenic nerve involved by stage III thymoma","volume":"89","author":"Yano","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib69","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.athoracsur.2015.04.059","article-title":"Surgical outcomes of patients with Stage III thymoma in the Japanese nationwide database","volume":"100","author":"Yamada","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib70","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.21037\/jtd-2019-thym-01","article-title":"Classification and staging of thymoma","volume":"12","author":"Markowiak","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jtho.2026.103611_bib71","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/j.cllc.2019.06.011","article-title":"Clinical outcomes of up-front surgery versus surgery after induction chemotherapy for thymoma and thymic carcinoma: a retrospective study","volume":"20","author":"Ma","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib72","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejca.2021.11.028","article-title":"Treatment strategies for thymic carcinoma in a real-life setting. Insights from the RYTHMIC network","volume":"162","author":"Petat","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.athoracsur.2012.03.062","article-title":"Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients","volume":"94","author":"Cardillo","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib74","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00595-020-02070-y","article-title":"Surgical management of thymic epithelial tumors","volume":"51","author":"Shintani","year":"2021","journal-title":"Surg Today"},{"key":"10.1016\/j.jtho.2026.103611_bib75","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.lungcan.2013.11.015","article-title":"Outcome of surgically resected thymic carcinoma: a multicenter experience","volume":"83","author":"Filosso","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtcvs.2013.08.061","article-title":"Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial","volume":"147","author":"Korst","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib77","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ejcts.2010.11.026","article-title":"Surgical treatment of stage III thymic tumors: a multi-institutional review from four Italian centers","volume":"39","author":"Marulli","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib78","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.lungcan.2016.01.008","article-title":"Induction therapy followed by surgical resection in Stage-III thimic epithelial tumors: long-term results from a multicentre analysis of 108 cases","volume":"93","author":"Cardillo","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib79","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jtho.2016.09.118","article-title":"Radiologic response to neoadjuvant treatment predicts histologic response in thymic epithelial tumors","volume":"12","author":"Johnson","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib80","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00408-013-9465-5","article-title":"The impact of neoadjuvant chemotherapy on the histopathological assessment of thymomas: a clinicopathological correlation of 28 cases treated with a similar regimen","volume":"191","author":"Weissferdt","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.jtho.2026.103611_bib81","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/his.15047","article-title":"Dataset for reporting of thymic epithelial tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"83","author":"Roden","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.jtho.2026.103611_bib82","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.athoracsur.2020.07.069","article-title":"Outcomes and safety analysis in superior vena cava resection for extended thymic epithelial tumors","volume":"112","author":"Bertolaccini","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib83","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.ejso.2014.05.011","article-title":"Outcomes after surgical resection of thymic carcinoma: a study from a single tertiary referral centre","volume":"40","author":"Song","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib84","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11748-018-0996-9","article-title":"Analysis of surgical treatment of Masaoka stage III\u2013IV thymic epithelial tumors","volume":"66","author":"Hamanaka","year":"2018","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib85","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ejcts\/ezy448","article-title":"Report from the European Society of Thoracic Surgeons prospective thymic database 2017: a powerful resource for a collaborative global effort to manage thymic tumours","volume":"55","author":"Ruffini","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib86","doi-asserted-by":"crossref","DOI":"10.1093\/ejcts\/ezac021","article-title":"Surgical resection of Masaoka stage III thymic epithelial tumours with great vessels involvement: a retrospective multicentric analysis from the European Society of Thoracic Surgeons Thymic database","volume":"62","author":"Mendogni","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib87","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/1759-7714.15198","article-title":"Characteristics and outcome of systemic treatment for metastatic or unresectable thymic carcinoma: a single institution experience","volume":"15","author":"Ho","year":"2024","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib88","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.3390\/cancers13133355","article-title":"Vascular involvement in thymic epithelial tumors: surgical and oncological outcomes","volume":"13","author":"Comacchio","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtho.2026.103611_bib89","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3857\/roj.2013.31.3.131","article-title":"Invasion of the great vessels or atrium predicts worse prognosis in thymic carcinoma","volume":"31","author":"Eom","year":"2013","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.jtho.2026.103611_bib90","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.athoracsur.2013.04.057","article-title":"Importance of lymph node dissection in thymic carcinoma","volume":"96","author":"Park","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib91","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3390\/cancers15082262","article-title":"Clinical outcomes of thymic carcinoma: the role of radiotherapy combined with multimodal treatments","volume":"15","author":"Yang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtho.2026.103611_bib92","first-page":"465","article-title":"[Role of postoperative radiotherapy for Stage I\/II\/III thymic tumor - results of the ChART retrospective database]","volume":"19","author":"Liu","year":"2016","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10.1016\/j.jtho.2026.103611_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146609","article-title":"Adjuvant therapy for thymic carcinoma--A decade of experience in a Taiwan national teaching hospital","volume":"11","author":"Tseng","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2026.103611_bib94","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.athoracsur.2012.09.006","article-title":"Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients","volume":"95","author":"Weksler","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107214","article-title":"Unradical Surgery for Locally-Advanced thymoma: is it time to evolve Perspectives?","volume":"180","author":"Mastromarino","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib96","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jtho.2017.01.002","article-title":"The impact of postoperative radiotherapy for thymoma and thymic carcinoma","volume":"12","author":"Jackson","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib97","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jtcvs.2014.09.124","article-title":"Thymic carcinoma outcomes and prognosis: results of an international analysis","volume":"149","author":"Ahmad","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib98","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jtho.2023.12.011","article-title":"Postoperative radiation therapy for thymic carcinoma: an analysis of the international thymic malignancy interest group\/European Society of Thoracic Surgeons database","volume":"19","author":"Rimner","year":"2024","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib99","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jtho.2016.06.011","article-title":"Postoperative radiation therapy is associated with longer overall survival in completely resected Stage II and III thymoma-an analysis of the international thymic malignancies interest group retrospective database","volume":"11","author":"Rimner","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib100","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/jso.26593","article-title":"Prognostic factors for survival in advanced thymomas: the role of the number of involved structures","volume":"124","author":"Chiappetta","year":"2021","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib101","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.jtho.2016.07.032","article-title":"Postoperative radiotherapy in locally invasive malignancies of the thymus: patterns of care and survival","volume":"11","author":"Boothe","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib102","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.semradonc.2017.11.002","article-title":"Does proton therapy offer demonstrable clinical advantages for treating thoracic tumors?","volume":"28","author":"Liao","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3857\/roj.2023.00360","article-title":"Comparison of radiotherapy techniques in patients with thymic epithelial tumor who underwent postoperative radiotherapy","volume":"42","author":"Lee","year":"2024","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.jtho.2026.103611_bib104","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.ijrobp.2023.06.792","article-title":"Treatment of thymoma and thymic carcinoma with proton beam therapy: outcomes from the proton collaborative group prospective registry","volume":"117","author":"Tian","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtho.2026.103611_bib105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.radonc.2016.02.003","article-title":"Prospective study of proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma: early response and toxicity assessment","volume":"118","author":"Vogel","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib106","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jtho.2017.11.118","article-title":"Paraneoplastic syndromes and thymic malignancies: an examination of the international thymic malignancy interest group retrospective database","volume":"13","author":"Padda","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib107","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood.V96.12.3872","article-title":"Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease","volume":"96","author":"Hoffacker","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtho.2026.103611_bib108","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/rheumatology\/39.9.1044","article-title":"Thymoma-associated systemic lupus erythematosus, exacerbating after thymectomy. A case report and review of the literature","volume":"39","author":"Boonen","year":"2000","journal-title":"Rheumatol (Oxf Engl)"},{"key":"10.1016\/j.jtho.2026.103611_bib109","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jtho.2026.103611_bib110","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/WNL.57.9.1579","article-title":"Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?","volume":"57","author":"Buckley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jtho.2026.103611_bib111","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.humpath.2015.10.007","article-title":"CXCR4 overexpression correlates with poor prognosis in myasthenia gravis-associated thymoma","volume":"49","author":"Wang","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtho.2026.103611_bib112","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s10072-019-04213-7","article-title":"The associations of HLA-DRB1 gene polymorphisms with late-onset myasthenia gravis: a meta-analysis","volume":"41","author":"Ling","year":"2020","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jtho.2026.103611_bib113","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/acn3.24","article-title":"Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker","volume":"1","author":"Punga","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jtho.2026.103611_bib114","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neulet.2011.08.021","article-title":"Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis","volume":"504","author":"Fenoglio","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jtho.2026.103611_bib115","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1756130","article-title":"Heat shock protein 90\u03b1 in thymic epithelial tumors and non-thymomatous myasthenia gravis","volume":"9","author":"Thanner","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jtho.2026.103611_bib172","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(18)30062-7","article-title":"Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study","volume":"19","author":"Giaccone","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib173","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1200\/JCO.2017.77.3184","article-title":"Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial","volume":"37","author":"Cho","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib174","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2019.03.012","article-title":"Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study","volume":"113","author":"Katsuya","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s40425-019-0723-9","article-title":"Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma","volume":"7","author":"Rajan","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib176","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S1470-2045(22)00542-3","article-title":"Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial","volume":"23","author":"Conforti","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib177","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejca.2022.06.059","article-title":"Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study","volume":"174","author":"Wang","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib178","doi-asserted-by":"crossref","first-page":"1516297","DOI":"10.3389\/fimmu.2025.1516297","article-title":"Case Report: Robust and durable response to the combination of tislelizumab and chemotherapy in advanced thymic epithelial tumors: a case series","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtho.2026.103611_bib179","article-title":"Preliminary efficacy, safety, and immunomodulatory effects of PT-112 from a phase 2 proof of concept study in patients (pts) with thymic epithelial tumors (TETs)","volume":"41","author":"McAdams","year":"2023","journal-title":"Am Soc Clin Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib180","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(25)00001-4","article-title":"Activity and safety of atezolizumab plus carboplatin and paclitaxel in patients with advanced or recurrent thymic carcinoma (MARBLE): a multicentre, single-arm, phase 2 trial","volume":"6","author":"Shukuya","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib181","first-page":"101576","article-title":"Efficacy and safety of nivolumab plus ipilimumab for patients with pre-treated type B3 thymoma and thymic carcinoma: Results from the EORTC-ETOP NIVOTHYM phase II trial, Am Soc","volume":"8","author":"Girard","year":"2025","journal-title":"Clin Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib182","doi-asserted-by":"crossref","first-page":"101576","DOI":"10.1016\/j.esmoop.2023.101576","article-title":"Efficacy and safety of nivolumab for patients with pre-treated type B3 thymoma and thymic carcinoma: results from the EORTC-ETOP NIVOTHYM phase II trial","volume":"8","author":"Girard","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.jtho.2026.103611_bib116","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1021\/acschemneuro.9b00678","article-title":"Unraveling the role of receptor for advanced glycation end products (RAGE) and its ligands in myasthenia gravis","volume":"11","author":"Angelopoulou","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.jtho.2026.103611_bib117","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clim.2011.04.013","article-title":"Activation of the receptor for advanced glycation end products (RAGE) exacerbates experimental autoimmune myasthenia gravis symptoms","volume":"141","author":"Mu","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jtho.2026.103611_bib118","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtho.2026.103611_bib119","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1210\/js.2017-00432","article-title":"Patients with antithyroid antibodies are prone to develop destructive thyroiditis by nivolumab: a prospective study","volume":"2","author":"Kobayashi","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jtho.2026.103611_bib120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.12688\/f1000research.22715.1","article-title":"Predicting response and toxicity to PD-1 inhibition using serum autoantibodies identified from immuno-mass spectrometry","volume":"9","author":"Music","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.jtho.2026.103611_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100415","article-title":"The clinical utility of comprehensive measurement of autoimmune disease-related antibodies in patients with advanced solid tumors receiving immune checkpoint inhibitors: a retrospective study","volume":"7","author":"Izawa","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.jtho.2026.103611_bib122","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1007\/s00262-021-02996-3","article-title":"Risk factors for adverse events induced by immune checkpoint inhibitors in patients with non-small-cell lung cancer: a systematic review and meta-analysis","volume":"70","author":"Suazo-Zepeda","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jtho.2026.103611_bib123","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/jjco\/hyy201","article-title":"Correlation between blood cell count and outcome of melanoma patients treated with anti-PD-1 antibodies","volume":"49","author":"Nakamura","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib124","doi-asserted-by":"crossref","first-page":"114268","DOI":"10.18632\/oncotarget.23217","article-title":"Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors","volume":"8","author":"Diehl","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2026.103611_bib125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.lungcan.2020.08.015","article-title":"Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors","volume":"150","author":"Chu","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2018.11.009","article-title":"Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors","volume":"107","author":"Hasan Ali","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib127","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2337\/dbi18-0002","article-title":"Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors","volume":"67","author":"Stamatouli","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.jtho.2026.103611_bib128","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1089\/thy.2020.0075","article-title":"Immune checkpoint inhibitor-induced thyroiditis is associated with increased intrathyroidal T lymphocyte subpopulations","volume":"30","author":"Kotwal","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.jtho.2026.103611_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1096806","article-title":"Association between germ-line HLA and immune-related adverse events","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtho.2026.103611_bib130","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41416-018-0074-1","article-title":"Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients","volume":"118","author":"Bins","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib131","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12943-020-01274-7","article-title":"The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors","volume":"19","author":"Jin","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib132","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132334","article-title":"MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors","volume":"5","author":"Marschner","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtho.2026.103611_bib133","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40425-015-0081-1","article-title":"Baseline circulating IL-17 predicts toxicity while TGF-\u03b21 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma","volume":"3","author":"Tarhini","year":"2015","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib134","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12967-018-1467-x","article-title":"Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade","volume":"16","author":"Valpione","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.jtho.2026.103611_bib135","article-title":"Thymic lymphoepithelial carcinoma: a rare aggressive mediastinal Mass","volume":"16","author":"Kedilaya","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jtho.2026.103611_bib136","first-page":"54","article-title":"Successful multimodal treatment of stage IV lymphoepithelioma-like thymic carcinoma","volume":"19","author":"Zieli\u0144ska","year":"2022","journal-title":"Kardiochir Torakochirurgia Pol"},{"key":"10.1016\/j.jtho.2026.103611_bib137","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2008.26.15_suppl.19087","article-title":"A phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma","volume":"26","author":"Bedano","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib138","doi-asserted-by":"crossref","DOI":"10.1177\/0145561320923170","article-title":"Is surgery an inevitable treatment for advanced salivary lymphoepithelial carcinoma? Three case reports","volume":"100","author":"Lv","year":"2021","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.jtho.2026.103611_bib139","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1002\/cncr.10588","article-title":"Treatment and prognosis of thymic carcinoma: a retrospective analysis of 40 cases","volume":"94","author":"Ogawa","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib140","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/ejcts\/ezx090","article-title":"Surgical therapy of thymic tumours with pleural involvement: an ESTS Thymic Working Group Project","volume":"52","author":"Moser","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib141","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jtcvs.2019.08.037","article-title":"Long-term, disease-specific outcomes of thymic malignancies presenting with de novo pleural metastasis","volume":"159","author":"Choe","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib142","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.athoracsur.2014.01.042","article-title":"Thymoma patients with pleural dissemination: nationwide retrospective study of 136 cases in Japan","volume":"97","author":"Okuda","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib143","article-title":"Surgical cytoreduction and hyperthermic intrathoracic chemotherapy for thymic tumours with pleural spread is effective on survival: results from the multicentre German hyperthermic intrathoracic chemotherapy study","volume":"36","author":"Ried","year":"2023","journal-title":"Interdiscip CardioVasc Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib144","first-page":"161","article-title":"Extended surgical resections of advanced thymoma Masaoka stages III and IVa facilitate outcome","volume":"62","author":"Ried","year":"2014","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib145","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.athoracsur.2018.07.058","article-title":"Cytoreductive pleurectomy and intrathoracic chemohyperthermia for pleural relapse of thymomas","volume":"107","author":"Maury","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib146","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.18632\/oncotarget.27978","article-title":"Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type","volume":"12","author":"Padda","year":"2021","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2026.103611_bib147","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/oncolo\/oyac115","article-title":"Comprehensive genomic profiling of 274 thymic epithelial tumors unveils oncogenic pathways and predictive biomarkers","volume":"27","author":"Girard","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.jtho.2026.103611_bib148","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.cllc.2024.01.001","article-title":"Trop-2 expression and its impact on survival in thymic epithelial tumors: brief report","volume":"25","author":"Ardeshir-Larijani","year":"2024","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib149","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2007.25.18_suppl.14148","article-title":"Clinical outcome of patients with thymic epithelial tumors","volume":"25","author":"Palmieri","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib183","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1200\/jco.2005.23.16_suppl.7068","article-title":"Phase II study of gefitinib treatment in advanced thymic malignancies","volume":"23","author":"Kurup","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib184","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1470-2045(14)71181-7","article-title":"Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial","volume":"16","author":"Thomas","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib185","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1200\/JCO.2017.74.4078","article-title":"Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy","volume":"36","author":"Zucali","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib186","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1470-2045(20)30162-5","article-title":"Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial","volume":"21","author":"Sato","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib187","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/s41591-025-03600-2","article-title":"A B7H3-targeting antibody\u2013drug conjugate in advanced solid tumors: a phase 1\/1b trial","volume":"31","author":"Ma","year":"2025","journal-title":"Nature Med"},{"key":"10.1016\/j.jtho.2026.103611_bib188","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.annonc.2024.06.002","article-title":"Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)","volume":"35","author":"Proto","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib189","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S1470-2045(25)00300-6","article-title":"Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial","volume":"26","author":"Remon","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib190","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cllc.2024.12.001","article-title":"Phase II parallel arm study of sacituzumab govitecan-hziy in patients with advanced thymoma or thymic carcinoma","volume":"26","author":"Marks","year":"2025","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib191","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12916-022-02361-w","article-title":"Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial","volume":"20","author":"Song","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.jtho.2026.103611_bib150","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.3390\/cancers13194794","article-title":"Thymic lymphoepithelial carcinoma associated with Epstein-Barr virus: experiences and literature review","volume":"13","author":"Ose","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtho.2026.103611_bib151","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13027-019-0254-5","article-title":"Association between Epstein-Barr virus and thymic epithelial tumors: a systematic review","volume":"14","author":"Zhang","year":"2019","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib152","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/PAS.0000000000001101","article-title":"Poorly differentiated nonkeratinizing squamous cell carcinoma of the thymus: clinicopathologic and molecular genetic study of 25 cases","volume":"42","author":"Suster","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jtho.2026.103611_bib153","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","article-title":"Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib154","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/ejcts\/ezv039","article-title":"Pleural recurrence of thymoma: surgical resection followed by hyperthermic intrathoracic perfusion chemotherapy","volume":"49","author":"Ambrogi","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib155","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/j.1471-4159.1989.tb07246.x","article-title":"Glutamate neurotoxicity in culture depends on the presence of glutamine: implications for the role of glial cells in normal and pathological brain development","volume":"52","author":"Simantov","year":"1989","journal-title":"J Neurochem"},{"key":"10.1016\/j.jtho.2026.103611_bib156","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.3390\/cancers14205035","article-title":"Subtotal pleurectomy with intrathoracic chemo hyperthermia (HITHOC) for IVa thymomas: de novo versus recurrent pleural disease","volume":"14","author":"Chappuy","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtho.2026.103611_bib157","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/icvts\/ivaa019","article-title":"Surgical treatment of pleural recurrence of thymoma: is hyperthermic intrathoracic chemotherapy worthwhile?","volume":"30","author":"Aprile","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib158","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/cancers13071559","article-title":"Which is the best treatment in recurrent thymoma? A systematic review and meta-analysis","volume":"13","author":"Chiappetta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtho.2026.103611_bib159","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0003-4975(90)90742-O","article-title":"Recurrent thymoma in patients with myasthenia gravis","volume":"50","author":"Ohmi","year":"1990","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib160","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/RCT.0000000000001407","article-title":"Radiomics analysis of multiphasic computed tomography images for distinguishing high-risk thymic epithelial tumors from low-risk thymic epithelial tumors","volume":"47","author":"Liufu","year":"2023","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.jtho.2026.103611_bib161","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.e20138","article-title":"Leveraging AI Predictive Models to Develop Thymic Tumor\u2013Specific Peptides Mimicking COL17A1 Alterations","volume":"43","author":"Ardeshir Larijani","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib162","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.annonc.2023.10.125","article-title":"Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review","volume":"35","author":"Prelaj","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtho.2026.103611_bib163","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.21037\/jtd-21-1948","article-title":"CT-based radiomics analysis for differentiation between thymoma and thymic carcinoma","volume":"14","author":"Ohira","year":"2022","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jtho.2026.103611_bib164","article-title":"Predicting the risk category of thymoma with machine learning-based computed tomography radiomics signatures and their between-imaging phase differences","volume":"14","author":"Liang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtho.2026.103611_bib165","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1186\/s12885-024-12394-4","article-title":"Deep learning for risk stratification of thymoma pathological subtypes based on preoperative CT images","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtho.2026.103611_bib166","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.4103\/jcrt.jcrt_865_22","article-title":"Evaluation of the relationship between the eighth edition of TNM staging, the mMasoaka, and World Health Organization histopathological classification for thymoma","volume":"19","author":"Sert","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.jtho.2026.103611_bib167","article-title":"Differential diagnosis between low risk and high-risk thymoma: comparison of diagnostic performance of radiologists with and without deep learning model","volume":"13","author":"Yoshida","year":"2024","journal-title":"Acta Radiol Open"},{"key":"10.1016\/j.jtho.2026.103611_bib168","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jtcvs.2022.05.046","article-title":"Machine learning-based radiomic computed tomography phenotyping of thymic epithelial tumors: predicting pathological and survival outcomes","volume":"165","author":"Tian","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtho.2026.103611_bib169","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtho.2026.103611_bib170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.748820","article-title":"Novel tumor-specific antigens for immunotherapy identified from multi-omics profiling in thymic carcinomas","volume":"12","author":"Fang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtho.2026.103611_bib171","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1038\/s41598-023-32339-4","article-title":"Proteomics analysis of serum from thymoma patients","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155608642600064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155608642600064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T09:23:59Z","timestamp":1778232239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155608642600064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":191,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S155608642600064X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2026.103611","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and Controversies in the Diagnosis and Management of Thymic Epithelial Tumors from the Thymic Tumor Subcommittee of the International Association for the Study of Lung Cancer Rare Tumors Committee","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2026.103611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103611"}}